MicroPort Endovascular MedTech Ltd - Asset Resilience Ratio

Latest as of March 2026: 20.69%

MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 20.69% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of MicroPort Endovascular MedTech Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥991.66 Million
≈ $145.11 Million USD Cash + Short-term Investments

Total Assets

CN¥4.79 Billion
≈ $701.48 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2025–2025)

This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. See 688016 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688016 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥991.66 Million 20.69%
Total Liquid Assets CN¥991.66 Million 20.69%

Asset Resilience Insights

  • Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 20.69% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio

Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
Medical Devices 49.23%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 5.73%
Shenzhen Lifotronic Technology Co
SHG:688389
Medical Devices 2.53%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%

Annual Asset Resilience Ratio for MicroPort Endovascular MedTech Ltd (2025–2025)

The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 2.16% CN¥100.37 Million
≈ $14.69 Million
CN¥4.64 Billion
≈ $679.15 Million
--
pp = percentage points

About MicroPort Endovascular MedTech Ltd

SHG:688016 China Medical Devices
Market Cap
$1.61 Billion
CN¥10.99 Billion CNY
Market Cap Rank
#7095 Global
#1621 in China
Share Price
CN¥89.18
Change (1 day)
-0.21%
52-Week Range
CN¥87.09 - CN¥121.45
All Time High
CN¥443.37
About

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more